Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

412 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transplanted CD34(+) cell dose is associated with long-term platelet count recovery following autologous peripheral blood stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma.
Stiff PJ, Micallef I, Nademanee AP, Stadtmauer EA, Maziarz RT, Bolwell BJ, Bridger G, Marulkar S, Hsu FJ, DiPersio JF. Stiff PJ, et al. Among authors: dipersio jf. Biol Blood Marrow Transplant. 2011 Aug;17(8):1146-53. doi: 10.1016/j.bbmt.2010.11.021. Epub 2010 Nov 30. Biol Blood Marrow Transplant. 2011. PMID: 21126595 Free article. Clinical Trial.
Donor CMV serostatus has no impact on CMV viremia or disease when prophylactic granulocyte transfusions are given following allogeneic peripheral blood stem cell transplantation.
Vij R, DiPersio JF, Venkatraman P, Trinkaus K, Goodnough LT, Brown RA, Khoury HJ, Devine SM, Oza A, Shenoy S, Blum W, Adkins D. Vij R, et al. Among authors: dipersio jf. Blood. 2003 Mar 1;101(5):2067-9. doi: 10.1182/blood-2002-07-2110. Epub 2002 Oct 24. Blood. 2003. PMID: 12406871 Free article.
High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.
Nash RA, Bowen JD, McSweeney PA, Pavletic SZ, Maravilla KR, Park MS, Storek J, Sullivan KM, Al-Omaishi J, Corboy JR, DiPersio J, Georges GE, Gooley TA, Holmberg LA, LeMaistre CF, Ryan K, Openshaw H, Sunderhaus J, Storb R, Zunt J, Kraft GH. Nash RA, et al. Blood. 2003 Oct 1;102(7):2364-72. doi: 10.1182/blood-2002-12-3908. Epub 2003 May 22. Blood. 2003. PMID: 12763935 Free PMC article. Clinical Trial.
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
Nash RA, Dansey R, Storek J, Georges GE, Bowen JD, Holmberg LA, Kraft GH, Mayes MD, McDonagh KT, Chen CS, Dipersio J, Lemaistre CF, Pavletic S, Sullivan KM, Sunderhaus J, Furst DE, McSweeney PA. Nash RA, et al. Biol Blood Marrow Transplant. 2003 Sep;9(9):583-91. doi: 10.1016/s1083-8791(03)00228-3. Biol Blood Marrow Transplant. 2003. PMID: 14506660 Free PMC article. Clinical Trial.
ASBMT committee report: white paper on measurement of quality outcomes.
Jones RB, Anasetti C, Appel P, DiPersio J, Heslop H, Lemaistre F, Silver S, Sirilla J, Stiff P; Committee on Hematopoietic Cell Therapy Quality Outcomes. Jones RB, et al. Biol Blood Marrow Transplant. 2006 May;12(5):594-7. doi: 10.1016/j.bbmt.2006.04.001. Biol Blood Marrow Transplant. 2006. PMID: 16635795 Free article. No abstract available.
Human progenitor cells rapidly mobilized by AMD3100 repopulate NOD/SCID mice with increased frequency in comparison to cells from the same donor mobilized by granulocyte colony stimulating factor.
Hess DA, Bonde J, Craft TP, Wirthlin L, Hohm S, Lahey R, Todt LM, Dipersio JF, Devine SM, Nolta JA. Hess DA, et al. Among authors: dipersio jf. Biol Blood Marrow Transplant. 2007 Apr;13(4):398-411. doi: 10.1016/j.bbmt.2006.12.445. Biol Blood Marrow Transplant. 2007. PMID: 17382247 Free PMC article.
412 results